TendieTensor TendieTensor
You’re browsing as
Guest
Free Preview
Sign in/sign up to unlock all features.

News  ›  GlobeNewswire Inc.

Shareholders of Telix Pharmaceuticals Ltd. Should Contact The Gross Law Firm Before January 9, 2026 to Discuss Your Rights – TLX

GlobeNewswire Inc. Logo GlobeNewswire Inc. By The Gross Law Firm
Shareholders of Telix Pharmaceuticals Ltd. Should Contact The Gross Law Firm Before January 9, 2026 to Discuss Your Rights – TLX

The Gross Law Firm has issued class action lawsuit notices for shareholders of Telix Pharmaceuticals (TLX), StubHub Holdings (STUB), and DeFi Technologies (DEFT). The primary focus is on Telix, which faces allegations of materially false statements regarding prostate cancer therapeutic progress, supply chain quality, and business prospects during the February-August 2025 period. The deadline for lead plaintiff registration is January 9, 2026 for Telix shareholders.

Insights
OKLO   neutral

Stock gave back 18% after 700% gains in 2025, but still has promising technology and potential regulatory progress


TLX   negative

Company faces class action allegations of materially false and misleading statements regarding prostate cancer therapeutic progress and supply chain quality, resulting in artificial stock inflation and investor losses.